A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab

PHASE2TerminatedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

September 4, 2020

Primary Completion Date

January 16, 2023

Study Completion Date

May 15, 2023

Conditions
Palmoplantar Pustulosis
Interventions
DRUG

Spesolimab

Spesolimab

Trial Locations (66)

1200

Brussels - UNIV Saint-Luc, Brussels

2145

Westmead Hospital, Westmead

2606

Paratus Clinical Research Woden, Phillip

3000

UZ Leuven, Leuven

3050

Royal Melbourne Hospital, Parkville

3053

Skin Health Institute Inc, Carlton

7632

University of Pecs, Pécs

9700

Markusovszky University Teaching Hospital, Szombathely

10002

National Taiwan University Hospital, Taipei

10117

Charité - Universitätsmedizin Berlin, Berlin

11000

Sanatorium Prof. Arenebergera, Prague

13620

Seoul National University Bundang Hospital, Seongnam

15213

University of Pittsburgh Medical Center, Pittsburgh

21565

Gachon University Gil Medical Center, Incheon

24105

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel

31059

HOP Larrey, Toulouse

35205

Total Skin and Beauty Dermatology Center, PC, Birmingham

60596

Universitätsklinikum Frankfurt, Frankfurt am Main

65212

University of Missouri Health System, Columbia

69120

Universitätsklinikum Heidelberg, Heidelberg

75010

HOP Saint-Louis, Paris

75246

Menter Dermatology Research Institute, Dallas

84107

University of Utah Health, Murray

91054

Universitätsklinikum Erlangen, Erlangen

194021

Dermatovenereological Dispensary #10, St. Petersburg, Saint Petersburg

420111

"LLC Medical Center Azbuka Zdorovia", Kazan'

454048

SBHI Chelyabinsk Reg.Clin.Derma.Dispen., Chelyabinsk

08520

The Psoriasis Treatment Center of Central New Jersey, East Windsor

E3B 1G9

Dr. Irina Turchin PC Inc., Fredericton

L4M 7G1

SimcoDerm Medical and Surgical Dermatology Centre, Barrie

N6A 3H7

The Guenther Dermatology Research Centre, London

H2X 2V1

Innovaderm Research Inc., Montreal

530 02

CCBR Czech a.s., Pardubice

100 34

Univ. Hospital Kralovske Vinohrady, Prague

06200

HOP l'Archet, Nice

470-1192

Fujita Health University Hospital, Aichi, Toyoake

272-8513

Tokyo Dental College Ichikawa General Hospital, Chiba, Ichikawa

814-0180

Fukuoka University Hospital, Fukuoka, Fukuoka

501-1194

Gifu University Hospital, Gifu, Gifu

078-8510

Asahikawa Medical University Hospital, Hokkaido, Asahikawa

080-0013

Takagi Dermatological Clinic, Hokkaido, Obihiro

760-0017

Takamatsu Red Cross Hospital, Kagawa, Takamatsu

252-0392

Sagamihara National Hospital, Kanagawa, Sagamihara

860-8556

Kumamoto University Hospital, Kumamoto, Kumamoto

602-8566

University Hospital Kyoto Prefectural University of Medicine, Kyoto, Kyoto

980-8574

Tohoku University Hospital, Miyagi, Sendai

390-8621

Shinshu University Hospital, Nagano, Matsumoto

700-8558

Okayama University Hospital, Okayama, Okayama

903-0215

University of the Ryukyus Hospital, Okinawa, Nakagami-gun

531-0071

Nakatsu Dermatology Clinic, Osaka, Osaka

545-8586

Osaka Metropolitan University Hospital, Osaka, Osaka

565-0871

Osaka University Hospital, Osaka, Suita

520-2192

Shiga University of Medical Science Hospital, Shiga, Otsu

329-0498

Jichi Medical University Hospital, Tochigi, Shimotsuke

173-8606

Teikyo University Hospital, Tokyo, Itabashi-ku

173-8610

Nihon University Itabashi Hospital, Tokyo, Itabashi-ku

160-0023

Tokyo Medical University Hospital, Tokyo, Shinjuku-ku

641-8509

Wakayama Medical University Hospital, Wakayama, Wakayama

31-559

Barbara Rewerska Diamond Clinic, Krakow, Krakow

90-436

Dermoklinika medical center, Lodz, Lodz

20-081

Independent Public Clin.Hosp.no1 Lublin, Lublin

10-229

Municipal Hospital Complex in Olsztyn, Olsztyn

51-318

Dermmedica Sp. z o.o., Wroclaw, Wroclaw

03080

Seoul National University Hospital, Seoul

EX2 5DW

Royal Devon and Exeter Hospital, Exeter

SE1 9RT

Guy's Hospital, London

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY